| 截至月份: | 2025年8月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 醫思健康 | | | | | | 呈交日期: | 2025年9月3日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02138 | 說明 | | | | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | --- | --- | --- | --- | --- | --- | --- | | 上月底結存 | | 38,000,000,000 | HKD | 0.00001 | HKD | 380,000 | | 增加 / 減少 (-) | | | | | HKD | | | 本月底結存 | | 38,000,000,00 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並表明概不就因本公告之全部或任何部份內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 EC Healthcare 醫思健康 （於開曼群島註冊成立之有限公司） （股份代號：2138） 於二零二五年八月二十二日舉行之 股東週年大會之投票結果 除非文義另有所指，本公佈所用詞彙與二零二五年七月三十一日之本公司通函（「通函」）所 界定者具相同涵義。 股東週年大會出席人士 於股東週年大會當日，本公司之已發行股本（「股份」）為1,185,211,265股股份，此乃賦予持 有人權利出席股東週年大會，並於會上表決贊成或反對所有決議案之股份總數。持有 708,220,934 股股份總數（佔股份總數的 59.75%）的股東（親身出席或委託代理人）出席了股 東週年大會。 概無任何股份賦予持有人權利出席股東週年大會但根據香港聯合交易所有限公司證券上市規則 （「上市規則」）第 13.40 條所載須放棄表決贊成決議案，亦無任何股份其持有人須根據上市 規則規定於股東週年大會上放棄表決權。概無本公司之股東於通函中表示有意在股 ...

Core Viewpoint - Medical technology company, Yisi Health (02138), has seen its stock price increase by over 70% in the last three trading days, with a current price of 1.09 HKD and a trading volume of 14.21 million HKD [1] Group 1: Strategic Partnership - In May, Yisi Health and Yimai Sunshine held a strategic cooperation signing ceremony in Hong Kong, establishing the "Yimai Yisi Health Technology Alliance" [1] - The partnership aims to create a dual-engine supply chain platform combining "centralized procurement + global distribution" [1] - The joint venture will integrate Yimai Sunshine's strengths in medical imaging equipment, supply chain, and department operation management with Yisi Health's channel resources in Hong Kong, Macau, and overseas markets [1] Group 2: Company Profile - Yisi Health is the largest non-hospital medical service supplier in Hong Kong, focusing on precision and preventive healthcare [1] - The company aims to become a leading one-stop health ecosystem, providing comprehensive medical services including health checks, vaccinations, laboratory testing, imaging diagnostics, primary care, specialist consultations, dental care, and pain management [1]

Core Viewpoint - Medical Mind Health (02138) has seen a significant stock price increase of over 70% in the last three trading days, with a current price of 1.09 HKD and a trading volume of 14.21 million HKD [1] Group 1: Strategic Partnership - In May of this year, Yimai Sunshine and Medical Mind Health held a strategic cooperation signing ceremony in Hong Kong, officially establishing the "Yimai Medical Mind Health Technology Alliance" [1] - The partnership aims to create a dual-engine supply chain platform combining "centralized procurement + global distribution" [1] - The joint venture will integrate Yimai Sunshine's core advantages in medical imaging equipment, supply chain of consumables, and department operation management with Medical Mind Health's channel resources in Hong Kong, Macau, and overseas markets [1] Group 2: Company Overview - Medical Mind Health is the largest non-hospital medical service supplier in Hong Kong, focusing on precision and preventive healthcare [1] - The company aims to become a leading one-stop health ecosystem, providing comprehensive medical services including health checks, vaccination, laboratory testing, imaging diagnostics, primary care, specialist consultations, dental services, and pain management [1]

Company Overview - Medical Health is the largest non-hospital medical service provider in Hong Kong, focusing on preventive and precision medicine, aiming to create a leading one-stop health ecosystem [4] - The company offers a comprehensive range of medical services, including health checks, vaccination, laboratory testing, imaging diagnostics, primary care, specialist consultations, dental care, and pain management [4] - Medical Health operates 182 service points across approximately 657,000 square feet and has 46 diversified brands to cater to both high-end and mass-market needs [4] Financial Performance - As of March 31, 2025, Medical Health reported total revenue of 3.821 billion yuan, a year-on-year decrease of 1.68% [2] - The company recorded a net loss attributable to shareholders of 154 million yuan, a significant year-on-year decrease of 782.39% [2] - The gross profit margin stands at 80.73%, with a debt-to-asset ratio of 56.14% [2] Market Position and Valuation - Medical Health's price-to-earnings (P/E) ratio is -4.82, ranking 91st in the healthcare equipment and services industry, which has an average P/E ratio of 0.69 and a median of 1.36 [3] - The stock has seen a cumulative increase of 19.3% over the past month, but only 1.49% year-to-date, underperforming the Hang Seng Index, which has risen by 27.22% [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年7月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 醫思健康 | | | | | | 呈交日期: | 2025年8月6日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02138 | 說明 | | | | | | 法定/註冊股份數目 | | | 面值 | 法定/註冊股本 | | | --- | --- | --- | --- | --- | --- | --- | | 上月底結存 | | 38,000,000,000 | HKD | 0.00001 HKD | | 380,000 | | 增加 / 減少 (-) | | | | HKD | | | | 本月底結存 | | 38,000,000,00 ...

第二節－環境 | 2.1 | 概覽 | 12 | | --- | --- | --- | | | 2.1.1 環境建築倡議 | 12 | | | 2.1.2 排放 | 13 | | | 2.1.3 能源管理 | 15 | | | 2.1.4 用水管理 | 15 | | | 2.1.5 廢棄物管理 | 16 | 第三節－社會 | 3.1 | 概覽 | 17 | | --- | --- | --- | | | 3.1.1 社區外展 | 18 | | | 3.1.2 社會責任 | 20 | | | 3.1.3 員工關係管理 | 24 | | | 3.1.4 多元平等與包容 | 27 | | | 3.1.5 員工福祉 | 30 | | | 3.1.6 職業健康安全 | 32 | 第四節－企業管治 | 4.1 | 概覽 | 33 | | --- | --- | --- | | | 4.1.1 董事會管治 | 33 | | | 4.1.2 風險管治及風險管理框架 | 34 | | | 4.1.3 我們產品及服務的品質保證 | 38 | | | 4.1.4 可持續供應鏈管理 | 41 | | | 4.1.5 道德及負責任行 ...

EC Healthcare 醫思健康 | | 普通決議案 | 贊成 | 反對 | | --- | --- | --- | --- | | 1. | 考慮及採納截至二零二五年三月三十一日止年度之本公司及其附屬公司經審核綜合財務報表以 | | | | | 及本公司董事（「董事」）會及獨立核數師報告。 | | | | 2. | (a) 重選李向榮先生為執行董事。 | | | | | 重選陸韵晟先生為非執行董事。 (b) | | | | | (c) 重選梁楊世嫡女士為非執行董事。 | | | | | (d) 重選區雋先生為獨立非執行董事。 | | | | | (e) 授權董事會釐定董事酬金。 | | | | 3. | 續聘安永會計師事務所為本公司核數師並授權董事會釐定其酬金。 | | | | 4. | 授予董事一般授權以配發、發行及處理不超過於本決議案獲通過當日已發行股份總數（不包括 | | | | | 任何庫存股份）20%之額外股份（包括自庫存出售或轉讓庫存股份）。 | | | | 5. | 授予董事一般授權以購回不超過於本決議案獲通過當日已發行股份總數10%之股份（不包括任 | | | | | 何庫存股份）。 | ...

(Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司) (Stock Code/股份代號: 2138) Note: Corporate Communications include but are not limited to (a) the directors' report, its annual accounts together with a copy of the auditors' report and, where applicable, its summary financial report; (b) the interim report and, where applicable, summary interim report; (c) a notice of meeting; (d) a listing document; (e) a circular; and (f) a reply slip. N O T I F I C AT I O N L E T T E R 通 知 信 函 31 J ...

(Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司) (Stock Code/股份代號: 2138) N OT IF IC ATI ON LET TE R 通 知 信 函 Dear Shareholder, 31 July 2025 EC Healthcare (the "Company") Notice of Publication of Annual Report, Circular & Proxy Form ("Current Corporate Communications") The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.echealthcare.com and the HKEXnews website at www.hkexnews.hk. If you have elected to re ...